Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$183.43 - $232.67 $83,827 - $106,330
-457 Reduced 27.87%
1,183 $221,000
Q1 2023

Apr 27, 2023

BUY
$193.75 - $232.55 $6,200 - $7,441
32 Added 1.99%
1,640 $381,000
Q4 2022

Feb 01, 2023

SELL
$187.24 - $242.74 $49,618 - $64,326
-265 Reduced 14.15%
1,608 $325,000
Q3 2022

Oct 27, 2022

BUY
$177.23 - $227.44 $31,015 - $39,802
175 Added 10.31%
1,873 $357,000
Q2 2022

Aug 08, 2022

SELL
$181.58 - $368.0 $26,510 - $53,728
-146 Reduced 7.92%
1,698 $368,000
Q1 2022

Apr 28, 2022

BUY
$303.87 - $423.8 $191,741 - $267,417
631 Added 52.02%
1,844 $644,000
Q4 2021

Jan 28, 2022

SELL
$347.28 - $421.83 $93,071 - $113,050
-268 Reduced 18.1%
1,213 $461,000
Q3 2021

Nov 02, 2021

BUY
$405.61 - $524.84 $89,234 - $115,464
220 Added 17.45%
1,481 $601,000
Q2 2021

Jul 22, 2021

BUY
$372.84 - $481.5 $11,930 - $15,408
32 Added 2.6%
1,261 $597,000
Q1 2021

May 13, 2021

BUY
$361.28 - $504.76 $242,780 - $339,198
672 Added 120.65%
1,229 $472,000
Q4 2020

Feb 02, 2021

BUY
$292.7 - $370.96 $163,033 - $206,624
557 New
557 $206,000
Q3 2020

Nov 25, 2020

SELL
$268.51 - $400.74 $156,541 - $233,631
-583 Closed
0 $0
Q2 2020

Jul 23, 2020

BUY
$256.46 - $373.01 $149,516 - $217,464
583 New
583 $216,000
Q4 2019

Jan 28, 2020

SELL
$288.29 - $335.49 $333,839 - $388,497
-1,158 Closed
0 $0
Q3 2019

Oct 25, 2019

BUY
$266.84 - $378.23 $68,844 - $97,583
258 Added 28.67%
1,158 $352,000
Q2 2019

Jul 17, 2019

SELL
$300.59 - $368.15 $75,147 - $92,037
-250 Reduced 21.74%
900 $331,000
Q1 2019

Apr 30, 2019

BUY
$272.57 - $321.18 $313,455 - $369,357
1,150 New
1,150 $351,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.6B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.